Healthcare Sales & Marketing Network News: Junovan

Searching News Database: Junovan

HSMN NewsFeed - 27 Aug 2007
IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
Devices Oncology FDA

HSMN NewsFeed - 29 May 2007
IDM Pharma Names Timothy P. Walbert as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 May 2007
FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 May 2007
IDM Pharma Appoints Robert De Vaere as Senior Vice President and CFO
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2006
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Nov 2006
IDM Pharma Submits Filing for European Market Approval of Mepact(TM) (mifamurtide, Junovan(TM) in the US) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Oct 2006
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology FDA

Return to NewsFeed

Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 10 additional stories matching:
Junovan
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.